为您找到相关结果约283个

你是不是要搜索 期刊elotuzumab 点击跳转

Daratumumab, Elotuzumab, and the Development of Therapeutic Monoclonal Antibodies in Multiple Myeloma

Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study

Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination

Sequence matters: elotuzumab more effective if used before daratumumab

Toward further simplification of elotuzumab therapy by subcutaneous administration

Soluble SLAMF7 is a predictive biomarker for elotuzumab therapy

Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir,

The role of elotuzumab in the treatment of relapsed or refractory multiple myeloma

Downregulation of Chemokine CCL20 Involved in Myeloma Cells Resistant to Elotuzumab and Lenalidomide

Emerging combination therapies for the management of multiple myeloma: the role of elotuzumab

Managing Infusion Reactions to New Monoclonal Antibodies in Multiple Myeloma: Daratumumab and Elotuzumab

Elotuzumab in combination with pomalidomide and dexamethasone for the treatment of multiple myeloma

Real-World Clinical Outcomes in Patients With Multiple Myeloma Administered With Elotuzumab-Based Treatment

Carfilzomib, Elotuzumab and Dexamethasone for Relapsed or Refractory Myeloma Patients

A Review of Interstitial Pneumonitis Caused by Elotuzumab Through Case Discussions and Academic Writings

为您找到相关结果约283个

共283条页码: 2/19页15条/页